NSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarti Drugs Ltd: key numbers
- Share price
- ₹435.20
- Market cap
- ₹3,972 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 20.8×Sector 48.7×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Drugs Ltd
All →Aarti Drugs Board Meeting Date
Aarti Drugs Ltd intimated BSE and NSE of a board meeting on November 3, 2026, to consider audited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results declaration.
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Aarti Drugs Other Announcement
Aarti Drugs has updated its list of authorized personnel for determining materiality of events and making stock exchange disclosures, effective October 1, 2026.
Aarti Drugs Management Change
Aarti Drugs Ltd announced the retirement of Director Uday M. Patil and the appointment of new directors, including Adhish P. Patil as the Managing Director.
Aarti Drugs Investor Presentation: Key Takeaways
Aarti Drugs reports Q1 FY27 revenue of ₹704 Cr, up 19% YoY. Management focuses on scaling regulated market sales through high-margin formulations and oncology backward integration.
Aarti Drugs Annual General Meeting
Aarti Drugs Limited conducted its 41st Annual General Meeting on September 26, 2026, to consider various ordinary and special business resolutions.
Other share pledge announcements
All →Emami Share Pledge
Diwakar Finvest disclosed a pledge of 21.40 lakh Emami shares and a release of 41 lakh shares under Regulation 31. The filing states no monetary value.
Paisalo Digital Share Pledge
Promoter group entity Equilibrated Venture Cflow released pledge on 20 lakh Paisalo Digital shares worth ₹15.88 Crore. Shareholding remains unchanged at 20.64%.
- Value
- ₹15.88 Cr
Refex Industries Share Pledge
Refex Holding pledged shares to multiple entities, raising encumbered stake to 29.06% of capital. Pledged shares now total 51.37% of promoter holding.
Ginni Filaments Share Pledge
SBICAP Trustee released a pledge over 26,48,300 Ginni Filaments shares, cutting its stake to 9.06%. No cash changed hands in the encumbrance release.
Manipal Health Enterprises Share Pledge
Promoter entity MEMG International India Pvt Ltd released pledges over 72,50,000 and 72,42,951 shares of Manipal Health Enterprises. The 22 October 2026 release eases encumbrances in favour of Vistra ITCL and 360 One Prime.
Camlin Fine Sciences Share Pledge
Camlin Fine Sciences promoter-director Ashish Dandekar created pledges over 13.60 lakh shares worth ₹11.39 Cr. No change in shareholding; total pledged exposure rises for investors to monitor.
- Value
- ₹11.39 Cr